Bellantoni M F
Division of Geriatric Medicine, Johns Hopkins Medical School, Baltimore, MD, USA.
Am Fam Physician. 1996 Sep 1;54(3):986-92, 995-6.
Bone fragility resulting from osteoporosis places a significant percentage of elderly women and other patient groups at risk for bone fracture. Risk factors for osteoporosis include hypogonadal states (particularly menopause), smoking, low calcium intake, lack of weight-bearing exercise, family history and use of certain medications. Preventive strategies are based on achieving and maintaining optimal bone mass through diet, exercise, appropriate use of hormone replacement therapy and avoidance of adverse influences, particularly smoking and certain medications. Laboratory investigations are of limited use in the detection and assessment of osteoporosis, but new techniques may help physicians identify patients with accelerated bone metabolism. Currently, the most precise method of radiologically assessing osteoporosis is dual-energy x-ray absorptiometry. Many new agents for the treatment of osteoporosis are being examined. First-line therapies currently include alendronate and calcitonin. The choice of therapy must be individualized and combined with advice about nutrition and exercise, both to optimize bone density and to minimize the risk of trauma.
骨质疏松症导致的骨骼脆弱使很大比例的老年女性和其他患者群体面临骨折风险。骨质疏松症的风险因素包括性腺功能减退状态(尤其是绝经)、吸烟、钙摄入量低、缺乏负重运动、家族病史以及某些药物的使用。预防策略基于通过饮食、运动、适当使用激素替代疗法以及避免不良影响(尤其是吸烟和某些药物)来实现并维持最佳骨量。实验室检查在骨质疏松症的检测和评估中作用有限,但新技术可能有助于医生识别骨代谢加速的患者。目前,放射学评估骨质疏松症最精确的方法是双能X线吸收法。许多治疗骨质疏松症的新药正在接受检验。目前一线治疗药物包括阿仑膦酸盐和降钙素。治疗方案的选择必须个体化,并结合有关营养和运动的建议,以优化骨密度并将创伤风险降至最低。